The role of gap junctions in inflammatory and neoplastic disorders (Review)

Kanno Y and Loewenstein WR: Low-resistance coupling between gland cells. Some observations on intercellular contact membranes and intercellular space. Nature. 201:194–195. 1964. View Article : Google Scholar : PubMed/NCBI

Lawrence TS, Beers WH and Gilula NB: Transmission of hormonal stimulation by cell-to-cell communication. Nature. 272:501–506. 1978. View Article : Google Scholar : PubMed/NCBI

Zhou JZ and Jiang JX: Gap junction and hemichannel-independent actions of connexins on cell and tissue functions - an update. FEBS Lett. 588:1186–1192. 2014. View Article : Google Scholar : PubMed/NCBI

Tse G and Yan BP: Electrophysiological mechanisms of long and short QT syndromes: Insights from mouse models. Int J Cardiol Heart Vasc. In press.

Veeraraghavan R, Lin J, Hoeker GS, Keener JP, Gourdie RG and Poelzing S: Sodium channels in the Cx43 gap junction perinexus may constitute a cardiac ephapse: An experimental and modeling study. Pflugers Arch. 467:2093–2105. 2015. View Article : Google Scholar : PubMed/NCBI

Veeraraghavan R, Gourdie RG and Poelzing S: Mechanisms of cardiac conduction: A history of revisions. Am J Physiol Heart Circ Physiol. 306:H619–H627. 2014. View Article : Google Scholar : PubMed/NCBI

Koval M, Isakson BE and Gourdie RG: Connexins, pannexins and innexins: Protein cousins with overlapping functions. FEBS Lett. 588:11852014. View Article : Google Scholar : PubMed/NCBI

Tse G: Both transmural dispersion of repolarization and transmural dispersion of refractoriness are poor predictors of arrhythmogenicity: A role for the index of Cardiac Electrophysiological Balance (QT/QRS)? J Geriatr Cardiol. In press.

Harris AL: Emerging issues of connexin channels: Biophysics fills the gap. Q Rev Biophys. 34:325–472. 2001. View Article : Google Scholar

Söhl G and Willecke K: Gap junctions and the connexin protein family. Cardiovasc Res. 62:228–232. 2004. View Article : Google Scholar : PubMed/NCBI

Ke Q, Li L, Cai B, Liu C, Yang Y, Gao Y, Huang W, Yuan X, Wang T, Zhang Q, et al: Connexin 43 is involved in the generation of human-induced pluripotent stem cells. Hum Mol Genet. 22:2221–2233. 2013. View Article : Google Scholar : PubMed/NCBI

Becker DL, Thrasivoulou C and Phillips AR: Connexins in wound healing; perspectives in diabetic patients. Biochim Biophys Acta. 1818:2068–2075. 2012. View Article : Google Scholar

Crespo Yanguas S, Willebrords J, Maes M, da Silva TC, Veloso Alves Pereira I, Cogliati B, Zaidan Dagli ML and Vinken M: Connexins and pannexins in liver damage. EXCLI J. 15:177–186. 2016.PubMed/NCBI

Tse G and Yeo JM: Conduction abnormalities and ventricular arrhythmogenesis: The roles of sodium channels and gap junctions. Int J Cardiol Heart Vasc. 9:75–82. 2015.

Goldberg GS, Valiunas V and Brink PR: Selective permeability of gap junction channels. Biochim Biophys Acta. 1662:96–101. 2004. View Article : Google Scholar : PubMed/NCBI

Wilgenbus KK, Kirkpatrick CJ, Knuechel R, Willecke K and Traub O: Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int J Cancer. 51:522–529. 1992. View Article : Google Scholar : PubMed/NCBI

Bukauskas FF and Verselis VK: Gap junction channel gating. Biochim Biophys Acta. 1662:42–60. 2004. View Article : Google Scholar : PubMed/NCBI

Bao L, Sachs F and Dahl G: Connexins are mechanosensitive. Am J Physiol Cell Physiol. 287:C1389–C1395. 2004. View Article : Google Scholar : PubMed/NCBI

Tse G, Yeo JM, Tse V, Kwan J and Sun B: Gap junction inhibition by heptanol increases ventricular arrhythmogenicity by reducing conduction velocity without affecting repolarization properties or myocardial refractoriness in Langendorff-perfused mouse hearts. Mol Med Rep. 14:4069–4074. 2016.PubMed/NCBI

Musil LS and Goodenough DA: Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J Cell Biol. 115:1357–1374. 1991. View Article : Google Scholar : PubMed/NCBI

Bennett MV and Verselis VK: Biophysics of gap junctions. Semin Cell Biol. 3:29–47. 1992. View Article : Google Scholar : PubMed/NCBI

Meyer RA, Lampe PD, Malewicz B, Baumann WJ and Johnson RG: Enhanced gap junction formation with LDL and apolipoprotein B. Exp Cell Res. 196:72–81. 1991. View Article : Google Scholar : PubMed/NCBI

Meyer R, Malewicz B, Baumann WJ and Johnson RG: Increased gap junction assembly between cultured cells upon cholesterol supplementation. J Cell Sci. 96:231–238. 1990.PubMed/NCBI

O'Carroll SJ, Becker DL, Davidson JO, Gunn AJ, Nicholson LF and Green CR: The use of connexin-based therapeutic approaches to target inflammatory diseases. Methods Mol Biol. 1037:519–546. 2013. View Article : Google Scholar : PubMed/NCBI

Beyer EC and Berthoud VM: Gap junction synthesis and degradation as therapeutic targets. Curr Drug Targets. 3:409–416. 2002. View Article : Google Scholar : PubMed/NCBI

Plum A, Hallas G, Magin T, Dombrowski F, Hagendorff A, Schumacher B, Wolpert C, Kim J, Lamers WH, Evert M, et al: Unique and shared functions of different connexins in mice. Curr Biol. 10:1083–1091. 2000. View Article : Google Scholar : PubMed/NCBI

Scott CA, Tattersall D, O'Toole EA and Kelsell DP: Connexins in epidermal homeostasis and skin disease. Biochim Biophys Acta. 1818:1952–1961. 2012. View Article : Google Scholar

Richard G: Connexin disorders of the skin. Clin Dermatol. 23:23–32. 2005. View Article : Google Scholar : PubMed/NCBI

Labarthe MP, Bosco D, Saurat JH, Meda P and Salomon D: Upregulation of connexin 26 between keratinocytes of psoriatic lesions. J Invest Dermatol. 111:72–76. 1998. View Article : Google Scholar : PubMed/NCBI

Lucke T, Choudhry R, Thom R, Selmer IS, Burden AD and Hodgins MB: Upregulation of connexin 26 is a feature of keratinocyte differentiation in hyperproliferative epidermis, vaginal epithelium, and buccal epithelium. J Invest Dermatol. 112:354–361. 1999. View Article : Google Scholar : PubMed/NCBI

Djalilian AR, McGaughey D, Patel S, Seo EY, Yang C, Cheng J, Tomic M, Sinha S, Ishida-Yamamoto A and Segre JA: Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response. J Clin Invest. 116:1243–1253. 2006. View Article : Google Scholar : PubMed/NCBI

Iossa S, Marciano E and Franzé A: GJB2 gene mutations in syndromic skin diseases with sensorineural hearing loss. Curr Genomics. 12:475–785. 2011. View Article : Google Scholar :

Levit NA and White TW: Connexin hemichannels influence genetically determined inflammatory and hyperproliferative skin diseases. Pharmacol Res. 99:337–343. 2015. View Article : Google Scholar : PubMed/NCBI

Masgrau-Peya E, Salomon D, Saurat JH and Meda P: In vivo modulation of connexins 43 and 26 of human epidermis by topical retinoic acid treatment. J Histochem Cytochem. 45:1207–1215. 1997. View Article : Google Scholar : PubMed/NCBI

Kanady JD, Dellinger MT, Munger SJ, Witte MH and Simon AM: Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Dev Biol. 354:253–266. 2011. View Article : Google Scholar : PubMed/NCBI

Meens MJ, Sabine A, Petrova TV and Kwak BR: Connexins in lymphatic vessel physiology and disease. FEBS Lett. 588:1271–1277. 2014. View Article : Google Scholar : PubMed/NCBI

Wick N, Saharinen P, Saharinen J, Gurnhofer E, Steiner CW, Raab I, Stokic D, Giovanoli P, Buchsbaum S, Burchard A, et al: Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro. Physiol Genomics. 28:179–192. 2007. View Article : Google Scholar : PubMed/NCBI

Finegold DN, Schacht V, Kimak MA, Lawrence EC, Foeldi E, Karlsson JM, Baty CJ and Ferrell RE: HGF and MET mutations in primary and secondary lymphedema. Lymphat Res Biol. 6:65–68. 2008. View Article : Google Scholar : PubMed/NCBI

Finegold DN, Baty CJ, Knickelbein KZ, Perschke S, Noon SE, Campbell D, Karlsson JM, Huang D, Kimak MA, Lawrence EC, et al: Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment. Clin Cancer Res. 18:2382–2390. 2012. View Article : Google Scholar : PubMed/NCBI

Losa D and Chanson M: The lung communication network. Cell Mol Life Sci. 72:2793–2808. 2015. View Article : Google Scholar : PubMed/NCBI

Freund-Michel V, Muller B, Marthan R, Savineau JP and Guibert C: Expression and role of connexin-based gap junctions in pulmonary inflammatory diseases. Pharmacol Ther. 164:105–119. 2016. View Article : Google Scholar : PubMed/NCBI

Okamoto T, Akiyama M, Takeda M, Gabazza EC, Hayashi T and Suzuki K: Connexin32 is expressed in vascular endothelial cells and participates in gap-junction intercellular communication. Biochem Biophys Res Commun. 382:264–268. 2009. View Article : Google Scholar : PubMed/NCBI

Ram A, Singh SK, Singh VP, Kumar S and Ghosh B: Inhaled carbenoxolone prevents allergic airway inflammation and airway hyperreactivity in a mouse model of asthma. Int Arch Allergy Immunol. 149:38–46. 2009. View Article : Google Scholar

Tamaya T, Sato S and Okada HH: Possible mechanism of steroid action of the plant herb extracts glycyrrhizin, glycyrrhetinic acid, and paeoniflorin: Inhibition by plant herb extracts of steroid protein binding in the rabbit. Am J Obstet Gynecol. 155:1134–1139. 1986. View Article : Google Scholar : PubMed/NCBI

Park SJ, Lee KS, Kim SR, Min KH, Lee KY, Choe YH, Park SY, Hong SH and Lee YC: Change of connexin 37 in allergen-induced airway inflammation. Exp Mol Med. 39:629–640. 2007. View Article : Google Scholar : PubMed/NCBI

Koval M, Billaud M, Straub AC, Johnstone SR, Zarbock A, Duling BR and Isakson BE: Spontaneous lung dysfunction and fibrosis in mice lacking connexin 40 and endothelial cell connexin 43. Am J Pathol. 178:2536–2546. 2011. View Article : Google Scholar : PubMed/NCBI

Kim J, Hwangbo C, Hu X, Kang Y, Papangeli I, Mehrotra D, Park H, Ju H, McLean DL, Comhair SA, et al: Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension. Circulation. 131:190–199. 2015. View Article : Google Scholar

Zhang J, Wang W, Sun J, Li Q, Liu J, Zhu H, Chen T, Wang H, Yu S and Sun G: Gap junction channel modulates pulmonary vascular permeability through calcium in acute lung injury: An experimental study. Respiration. 80:236–245. 2010. View Article : Google Scholar : PubMed/NCBI

Chadjichristos CE, Scheckenbach KE, van Veen TA, Richani Sarieddine MZ, de Wit C, Yang Z, Roth I, Bacchetta M, Viswambharan H and Foglia B: Endothelial-specific deletion of connexin40 promotes atherosclerosis by increasing CD73-dependent leukocyte adhesion. Circulation. 121:123–131. 2010. View Article : Google Scholar

Rignault S, Haefliger JA, Waeber B, Liaudet L and Feihl F: Acute inflammation decreases the expression of connexin 40 in mouse lung. Shock. 28:78–85. 2007. View Article : Google Scholar : PubMed/NCBI

O'Donnell JJ III, Birukova AA, Beyer EC and Birukov KG: Gap junction protein connexin43 exacerbates lung vascular permeability. PLoS One. 9:e1009312014. View Article : Google Scholar : PubMed/NCBI

Kasper M, Traub O, Reimann T, Bjermer L, Grossmann H, Müller M and Wenzel KW: Upregulation of gap junction protein connexin43 in alveolar epithelial cells of rats with radiation-induced pulmonary fibrosis. Histochem Cell Biol. 106:419–424. 1996. View Article : Google Scholar : PubMed/NCBI

Fernandez-Cobo M, Gingalewski C and De Maio A: Expression of the connexin 43 gene is increased in the kidneys and the lungs of rats injected with bacterial lipopolysaccharide. Shock. 10:97–102. 1998. View Article : Google Scholar : PubMed/NCBI

Zhang J, Yang GM, Zhu Y, Peng XY, Li T and Liu LM: Role of connexin 43 in vascular hyperpermeability and relationship to Rock1-MLC20 pathway in septic rats. Am J Physiol Lung Cell Mol Physiol. 309:L1323–L1332. 2015.PubMed/NCBI

Molina SA, Stauffer B, Moriarty HK, Kim AH, McCarty NA and Koval M: Junctional abnormalities in human airway epithelial cells expressing F508del CFTR. Am J Physiol Lung Cell Mol Physiol. 309:L475–L487. 2015. View Article : Google Scholar : PubMed/NCBI

Trovato-Salinaro A, Trovato-Salinaro E, Failla M, Mastruzzo C, Tomaselli V, Gili E, Crimi N, Condorelli DF and Vancheri C: Altered intercellular communication in lung fibroblast cultures from patients with idiopathic pulmonary fibrosis. Respir Res. 7:1222006. View Article : Google Scholar : PubMed/NCBI

Montani D, Günther S, Dorfmüller P, Perros F, Girerd B, Garcia G, Jaïs X, Savale L, Artaud-Macari E, Price LC, et al: Pulmonary arterial hypertension. Orphanet J Rare Dis. 8:972013. View Article : Google Scholar : PubMed/NCBI

Yen CH, Leu S, Lin YC, Kao YH, Chang LT, Chua S, Fu M, Wu CJ, Sun CK and Yip HK: Sildenafil limits monocrotaline-induced pulmonary hypertension in rats through suppression of pulmonary vascular remodeling. J Cardiovasc Pharmacol. 55:574–584. 2010. View Article : Google Scholar : PubMed/NCBI

Gairhe S, Bauer NN, Gebb SA and McMurtry IF: Myoendothelial gap junctional signaling induces differentiation of pulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 301:L527–L535. 2011. View Article : Google Scholar : PubMed/NCBI

Segretain D and Falk MM: Regulation of connexin biosynthesis, assembly, gap junction formation, and removal. Biochim Biophys Acta. 1662:3–21. 2004. View Article : Google Scholar : PubMed/NCBI

Patel SJ, King KR, Casali M and Yarmush ML: DNA-triggered innate immune responses are propagated by gap junction communication. Proc Natl Acad Sci USA. 106:12867–12872. 2009. View Article : Google Scholar : PubMed/NCBI

Naiki-Ito A, Asamoto M, Naiki T, Ogawa K, Takahashi S, Sato S and Shirai T: Gap junction dysfunction reduces acetaminophen hepatotoxicity with impact on apoptotic signaling and connexin 43 protein induction in rat. Toxicol Pathol. 38:280–286. 2010. View Article : Google Scholar : PubMed/NCBI

Asamoto M, Hokaiwado N, Murasaki T and Shirai T: Connexin 32 dominant-negative mutant transgenic rats are resistant to hepatic damage by chemicals. Hepatology. 40:205–210. 2004. View Article : Google Scholar : PubMed/NCBI

Hokaiwado N, Asamoto M, Futakuchi M, Ogawa K, Takahashi S and Shirai T: Both early and late stages of hepatocarcinogenesis are enhanced in Cx32 dominant negative mutant transgenic rats with disrupted gap junctional intercellular communication. J Membr Biol. 218:101–106. 2007. View Article : Google Scholar : PubMed/NCBI

Maes M, McGill MR, da Silva TC, Abels C, Lebofsky M, Maria Monteiro, de Araújo C, Tiburcio T, Veloso Alves Pereira I, Willebrords J, Crespo Yanguas S, et al: Involvement of connexin43 in acetaminophen-induced liver injury. Biochim Biophys Acta. 1862:1111–1121. 2016. View Article : Google Scholar : PubMed/NCBI

Balasubramaniyan V, Dhar DK, Warner AE, Vivien Li WY, Amiri AF, Bright B, Mookerjee RP, Davies NA, Becker DL and Jalan R: Importance of connexin-43 based gap junction in cirrhosis and acute-on-chronic liver failure. J Hepatol. 58:1194–1200. 2013. View Article : Google Scholar : PubMed/NCBI

Gotthardt D, Riediger C, Weiss KH, Encke J, Schemmer P, Schmidt J and Sauer P: Fulminant hepatic failure: etiology and indications for liver transplantation. Nephrol Dial Transplant. 22(Suppl 8): viii5–viii8. 2007. View Article : Google Scholar : PubMed/NCBI

Maes M, McGill MR, da Silva TC, Lebofsky M, Maria Monteiro, de Araújo C, Tiburcio T, Veloso Alves Pereira I, Willebrords J, Crespo Yanguas S, Farhood A, et al: Connexin32: A mediator of acetaminophen-induced liver injury? Toxicol Mech Methods. 26:88–96. 2016. View Article : Google Scholar : PubMed/NCBI

Igarashi I, Maejima T, Kai K, Arakawa S, Teranishi M and Sanbuissho A: Role of connexin 32 in acetaminophen toxicity in a knockout mice model. Exp Toxicol Pathol. 66:103–110. 2014. View Article : Google Scholar

Du K, Williams CD, McGill MR, Xie Y, Farhood A, Vinken M and Jaeschke H: The gap junction inhibitor 2-aminoethoxy-diphenyl-borate protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes and c-jun N-terminal kinase activation. Toxicol Appl Pharmacol. 273:484–491. 2013. View Article : Google Scholar : PubMed/NCBI

Patel SJ, Milwid JM, King KR, Bohr S, Iracheta-Vellve A, Li M, Vitalo A, Parekkadan B, Jindal R and Yarmush ML: Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure. Nat Biotechnol. 30:179–183. 2012. View Article : Google Scholar : PubMed/NCBI

Ogawa K, Pitchakarn P, Suzuki S, Chewonarin T, Tang M, Takahashi S, Naiki-Ito A, Sato S, Takahashi S, Asamoto M, et al: Silencing of connexin 43 suppresses invasion, migration and lung metastasis of rat hepatocellular carcinoma cells. Cancer Sci. 103:860–867. 2012. View Article : Google Scholar : PubMed/NCBI

Zhang D, Kaneda M, Nakahama K, Arii S and Morita I: Connexin 43 expression promotes malignancy of HuH7 hepatocellular carcinoma cells via the inhibition of cell-cell communication. Cancer Lett. 252:208–215. 2007. View Article : Google Scholar : PubMed/NCBI

Ionta M, Ferreira RA, Pfister SC and Machado-Santelli GM: Exogenous Cx43 expression decrease cell proliferation rate in rat hepatocarcinoma cells independently of functional gap junction. Cancer Cell Int. 9:222009. View Article : Google Scholar : PubMed/NCBI

Igarashi I, Makino T, Suzuki Y, Kai K, Teranishi M, Takasaki W and Furuhama K: Background lesions during a 24-month observation period in connexin 32-deficient mice. J Vet Med Sci. 75:207–210. 2013. View Article : Google Scholar

Loch-Caruso R, Galvez MM, Brant K and Chung D: Cell and toxicant specific phosphorylation of conexin43: Effects of lindane and TPA on rat myometrial and WB-F344 liver cell gap junctions. Cell Biol Toxicol. 20:147–169. 2004. View Article : Google Scholar : PubMed/NCBI

Mograbi B, Corcelle E, Defamie N, Samson M, Nebout M, Segretain D, Fénichel P and Pointis G: Aberrant connexin 43 endocytosis by the carcinogen lindane involves activation of the ERK/mitogen-activated protein kinase pathway. Carcinogenesis. 24:1415–1423. 2003. View Article : Google Scholar : PubMed/NCBI

Caruso RL, Upham BL, Harris C and Trosko JE: Biphasic lindane-induced oxidation of glutathione and inhibition of gap junctions in myometrial cells. Toxicol Sci. 86:417–426. 2005. View Article : Google Scholar : PubMed/NCBI

Defamie N, Mograbi B, Roger C, Cronier L, Malassine A, Brucker-Davis F, Fenichel P, Segretain D and Pointis G: Disruption of gap junctional intercellular communication by lindane is associated with aberrant localization of connexin43 and zonula occludens-1 in 42GPA9 Sertoli cells. Carcinogenesis. 22:1537–1542. 2001. View Article : Google Scholar : PubMed/NCBI

Weigelt B, Peterse JL and van't Veer LJ: Breast cancer metastasis: Markers and models. Nat Rev Cancer. 5:591–602. 2005. View Article : Google Scholar : PubMed/NCBI

Plante I, Stewart MK, Barr K, Allan AL and Laird DW: Cx43 suppresses mammary tumor metastasis to the lung in a Cx43 mutant mouse model of human disease. Oncogene. 30:1681–1692. 2011. View Article : Google Scholar

Sirnes S, Bruun J, Kolberg M, Kjenseth A, Lind GE, Svindland A, Brech A, Nesbakken A, Lothe RA, Leithe E, et al: Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome. Int J Cancer. 131:570–581. 2012. View Article : Google Scholar

Bernzweig J, Heiniger B, Prasain K, Lu J, Hua DH and Nguyen TA: Anti-breast cancer agents, quinolines, targeting gap junction. Med Chem. 7:448–453. 2011. View Article : Google Scholar : PubMed/NCBI

Liu CL, Huang YS, Hosokawa M, Miyashita K and Hu ML: Inhibition of proliferation of a hepatoma cell line by fucoxanthin in relation to cell cycle arrest and enhanced gap junctional inter-cellular communication. Chem Biol Interact. 182:165–172. 2009. View Article : Google Scholar : PubMed/NCBI

Soobrattee MA, Bahorun T and Aruoma OI: Chemopreventive actions of polyphenolic compounds in cancer. Biofactors. 27:19–35. 2006. View Article : Google Scholar : PubMed/NCBI

Wang L, Zeng Y, Liu Y, Hu X, Li S, Wang Y, Li L, Lei Z and Zhang Z: Fucoxanthin induces growth arrest and apoptosis in human bladder cancer T24 cells by up-regulation of p21 and down-regulation of mortalin. Acta Biochim Biophys Sin (Shanghai). 46:877–884. 2014. View Article : Google Scholar

Marchenko ND, Zaika A and Moll UM: Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem. 275:16202–16212. 2000. View Article : Google Scholar : PubMed/NCBI

Januar HI, Dewi AS, Marraskuranto E and Wikanta T: In silico study of fucoxanthin as a tumor cytotoxic agent. J Pharm Bioallied Sci. 4:56–59. 2012. View Article : Google Scholar : PubMed/NCBI

Nakamura Y, Chang CC, Mori T, Sato K, Ohtsuki K, Upham BL and Trosko JE: Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cells. Carcinogenesis. 26:665–671. 2005. View Article : Google Scholar

Ding Y and Nguyen TA: Gap junction enhancer potentiates cytotoxicity of cisplatin in breast cancer cells. J Cancer Sci Ther. 4:371–378. 2012. View Article : Google Scholar : PubMed/NCBI

Sáez CG, Velásquez L, Montoya M, Eugenín E and Alvarez MG: Increased gap junctional intercellular communication is directly related to the anti-tumor effect of all-trans-retinoic acid plus tamoxifen in a human mammary cancer cell line. J Cell Biochem. 89:450–461. 2003. View Article : Google Scholar : PubMed/NCBI

Wernyj RP and Morin PJ: Molecular mechanisms of platinum resistance: Still searching for the Achilles' heel. Drug Resist Updat. 7:227–232. 2004. View Article : Google Scholar : PubMed/NCBI

Peterson-Roth E, Brdlik CM and Glazer PM: Src-Induced cisplatin resistance mediated by cell-to-cell communication. Cancer Res. 69:3619–3624. 2009. View Article : Google Scholar : PubMed/NCBI

Isakov N, Bleackley RC, Shaw J and Altman A: Teleocidin and phorbol ester tumor promoters exert similar mitogenic effects on human lymphocytes. Biochem Biophys Res Commun. 130:724–731. 1985. View Article : Google Scholar : PubMed/NCBI

Procopio A, Gismondi A, Paolini R, Morrone S, Testi R, Piccoli M, Frati L, Herberman RB and Santoni A: Proliferative effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) and calcium ionophores on human large granular lymphocytes (LGL). Cell Immunol. 113:70–81. 1988. View Article : Google Scholar : PubMed/NCBI

Bigelow K and Nguyen TA: Increase of gap junction activities in SW480 human colorectal cancer cells. BMC Cancer. 14:5022014. View Article : Google Scholar : PubMed/NCBI

Leithe E and Rivedal E: Ubiquitination and down-regulation of gap junction protein connexin-43 in response to 12-O-tetradecanoylphorbol 13-acetate treatment. J Biol Chem. 279:50089–50096. 2004. View Article : Google Scholar : PubMed/NCBI

Solomon VR and Lee H: Quinoline as a privileged scaffold in cancer drug discovery. Curr Med Chem. 18:1488–1508. 2011. View Article : Google Scholar : PubMed/NCBI

Lim YC, Kang HJ, Kim YS and Choi EC: All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway. Eur J Cancer. 48:3310–3318. 2012. View Article : Google Scholar : PubMed/NCBI

Ara C, Massimi M and Devirgiliis Conti L: Retinoic acid modulates gap junctional intercellular communication in hepatocytes and hepatoma cells. Cell Mol Life Sci. 59:1758–1765. 2002. View Article : Google Scholar : PubMed/NCBI

Wang J, Dai Y, Huang Y, Chen X, Wang H, Hong Y, Xia J and Cheng B: All-trans retinoic acid restores gap junctional intercellular communication between oral cancer cells with upregulation of Cx32 and Cx43 expressions in vitro. Med Oral Patol Oral Cir Bucal. 18:e569–e577. 2013. View Article : Google Scholar : PubMed/NCBI

Belliveau DJ, Bechberger JF, Rogers KA and Naus CC: Differential expression of gap junctions in neurons and astrocytes derived from P19 embryonal carcinoma cells. Dev Genet. 21:187–200. 1997. View Article : Google Scholar : PubMed/NCBI

Bani-Yaghoub M, Bechberger JF and Naus CC: Reduction of connexin43 expression and dye-coupling during neuronal differentiation of human NTera2/clone D1 cells. J Neurosci Res. 49:19–31. 1997. View Article : Google Scholar : PubMed/NCBI

Rudkin GH, Carlsen BT, Chung CY, Huang W, Ishida K, Anvar B, Yamaguchi DT and Miller TA: Retinoids inhibit squamous cell carcinoma growth and intercellular communication. J Surg Res. 103:183–189. 2002. View Article : Google Scholar : PubMed/NCBI

Picus J and Schultz M: Docetaxel (Taxotere) as monotherapy in the treatment of hormone-refractory prostate cancer: Preliminary results. Semin Oncol. 26(Suppl 17): 14–18. 1999.PubMed/NCBI

Petrylak DP, Tangen CM, Hussain MH, Lara PN Jr, Jones JA, Taplin ME, Burch PA, Berry D, Moinpour C, Kohli M, et al: Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 351:1513–1520. 2004. View Article : Google Scholar : PubMed/NCBI

Hwang C: Overcoming docetaxel resistance in prostate cancer: A perspective review. Ther Adv Med Oncol. 4:329–340. 2012. View Article : Google Scholar : PubMed/NCBI

Fukushima M, Hattori Y, Yoshizawa T and Maitani Y: Combination of non-viral connexin 43 gene therapy and docetaxel inhibits the growth of human prostate cancer in mice. Int J Oncol. 30:225–231. 2007.

Tang N, Wang Q, Wu D, Zhang S, Zhang Y and Tao L: Differential effects of paclitaxel and docetaxel on gap junctions affects their cytotoxicities in transfected HeLa cells. Mol Med Rep. 8:638–644. 2013.PubMed/NCBI

Wang M, Berthoud VM and Beyer EC: Connexin43 increases the sensitivity of prostate cancer cells to TNFalpha-induced apoptosis. J Cell Sci. 120:320–329. 2007. View Article : Google Scholar : PubMed/NCBI

Nomura S, Maeda K, Noda E, Inoue T, Fukunaga S, Nagahara H and Hirakawa K: Clinical significance of the expression of connexin26 in colorectal cancer. J Exp Clin Cancer Res. 29:792010. View Article : Google Scholar : PubMed/NCBI

Knösel T, Emde A, Schlüns K, Chen Y, Jürchott K, Krause M, Dietel M and Petersen I: Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer. Neoplasia. 7:741–747. 2005. View Article : Google Scholar : PubMed/NCBI

Mesnil M, Krutovskikh V, Piccoli C, Elfgang C, Traub O, Willecke K and Yamasaki H: Negative growth control of HeLa cells by connexin genes: Connexin species specificity. Cancer Res. 55:629–639. 1995.PubMed/NCBI

Goulet AC, Watts G, Lord JL and Nelson MA: Profiling of selenomethionine responsive genes in colon cancer by microarray analysis. Cancer Biol Ther. 6:494–503. 2007. View Article : Google Scholar : PubMed/NCBI

Dilber MS and Gahrton G: Suicide gene therapy: Possible applications in haematopoietic disorders. J Intern Med. 249:359–367. 2001. View Article : Google Scholar : PubMed/NCBI

Mesnil M, Piccoli C, Tiraby G, Willecke K and Yamasaki H: Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci USA. 93:1831–1835. 1996. View Article : Google Scholar : PubMed/NCBI

Boucher PD, Ruch RJ and Shewach DS: Differential ganciclovir-mediated cytotoxicity and bystander killing in human colon carcinoma cell lines expressing herpes simplex virus thymidine kinase. Hum Gene Ther. 9:801–814. 1998. View Article : Google Scholar : PubMed/NCBI

Grek CL, Rhett JM and Ghatnekar GS: Cardiac to cancer: Connecting connexins to clinical opportunity. FEBS Lett. 588:1349–1364. 2014. View Article : Google Scholar : PubMed/NCBI

Tanaka T, Yamasaki H and Mesnil M: Induction of a bystander effect in HeLa cells by using a bigenic vector carrying viral thymidine kinase and connexin32 genes. Mol Carcinog. 30:176–180. 2001. View Article : Google Scholar : PubMed/NCBI

Mesnil M and Yamasaki H: Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: Role of gap-junctional intercellular communication. Cancer Res. 60:3989–3999. 2000.PubMed/NCBI

Azzam EI, de Toledo SM and Little JB: Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells. Proc Natl Acad Sci USA. 98:473–478. 2001.PubMed/NCBI

Eloff BC, Lerner DL, Yamada KA, Schuessler RB, Saffitz JE and Rosenbaum DS: High resolution optical mapping reveals conduction slowing in connexin43 deficient mice. Cardiovasc Res. 51:681–690. 2001. View Article : Google Scholar : PubMed/NCBI

Tse G: Mechanisms of cardiac arrhythmias. J Arrhythm. 32:75–81. 2016. View Article : Google Scholar : PubMed/NCBI

Tse G, Wong ST, Tse V, Lee YT, Lin HY and Yeo JM: Cardiac dynamics: Alternans and arrhythmogenesis. J Arrhythm. 32:411–417. 2016. View Article : Google Scholar : PubMed/NCBI

Schalper KA, Carvajal-Hausdorf D and Oyarzo MP: Possible role of hemichannels in cancer. Front Physiol. 5:2372014. View Article : Google Scholar : PubMed/NCBI

Tse G, Wong ST, Tse V and Yeo JM: Depolarization vs. repolarization: What is the mechanism of ventricular arrhythmogenesis underlying sodium channel haploinsufficiency in mouse hearts? Acta Physiol (Oxf). 218:234–235. 2016. View Article : Google Scholar

Tse G: (Tpeak-Tend)/QRS and (Tpeak-Tend)/(QT x QRS): Novel markers for predicting arrhythmic risk in the Brugada syndrome. Europace. Oct 5–2016.Epub ahead of print. View Article : Google Scholar

Tse G, Wong ST, Tse V and Yeo JM: Determination of action potential wavelength restitution in Scn5a/- mouse hearts modelling human Brugada syndrome. J Physiol. In press.

Tse G: Novel conduction repolarization indices for the stratification of arrhythmic risk. J Geriatr Cardiol. 13:811–812. 2016.PubMed/NCBI

Tse G, Wong ST, Tse V and Yeo JM: Variability in local action potential durations, dispersion of repolarization and wavelength restitution in aged wild type and Scn5a/- mouse hearts modelling human Brugada syndrome. J Geriatr Cardiol. In press.

Hu Z, Chen Z, Wang Y, et al: Effects of granulocyte colony-stimulating factor on rabbit carotid and swine heart models of chronic obliterative arterial disease. Mol Med Rep. In press.

Tse G, Tse V and Yeo JM: Ventricular anti-arrhythmic effects of heptanol in hypokalaemic, Langendorff-perfused mouse hearts. Biomed Rep. 4:313–324. 2016.PubMed/NCBI

Tse G, Tse V, Yeo JM and Sun B: Atrial anti-arrhythmic effects of heptanol in Langendorff-perfused mouse hearts. PLoS One. 11:e01488582016. View Article : Google Scholar : PubMed/NCBI

Tse G, Wong ST, Tse V and Yeo JM: Restitution analysis of alternans using dynamic pacing and its comparison with S1S2 restitution in heptanol-treated, hypokalaemic Langendorff-perfused mouse hearts. Biomed Rep. 4:673–680. 2016.PubMed/NCBI

Tse G, Wong ST, Tse V and Yeo JM: Monophasic action potential recordings: Which is the recording electrode? J Basic Clin Physiol Pharmacol. 27:457–462. 2016. View Article : Google Scholar : PubMed/NCBI

Tse G, Lai ET, Yeo JM, Tse V and Wong SH: Mechanisms of electrical activation and conduction in the gastrointestinal system: Lessons from cardiac electrophysiology. Front Physiol. 7:1822016.PubMed/NCBI

Tse G, Lai ET, Tse V and Yeo JM: Molecular and electrophysiological mechanisms underlying cardiac arrhythmogenesis in diabetes mellitus. J Diabetes Res. 2016:28487592016. View Article : Google Scholar : PubMed/NCBI

Tse G, Lai ET, Yeo JM and Yan BP: Electrophysiological mechanisms of Bayés syndrome: Insights from clinical and mouse studies. Front Physiol. 7:1882016.

Tse G, Sun B, Wong ST, Tse V and Yeo JM: Anti-arrhythmic effects of hypercalcaemia treatment in hyperkalaemic, Langendorff-perfused mouse hearts. Biomed Rep. 5:301–310. 2016.PubMed/NCBI

Chen Z, Sun B, Tse G, Jiang J and Xu W: Reversibility of both sinus node dysfunction and reduced HCN4 mRNA expression level in an atrial tachycardia pacing model of tachycardia-bradycardia syndrome in rabbit hearts. Int J Clin Exp Pathol. 9:8526–8531. 2016.

Tse G, Yeo JM, Chan YW, Lai ET and Yan BP: What is the arrhythmic substrate in viral myocarditis? Insights from clinical and animal studies. Front Physiol. 7:3082016. View Article : Google Scholar : PubMed/NCBI

Choy L, Yeo JM, Tse V, Chan SP and Tse G: Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse models. Int J Cardiol Heart Vasc. 12:1–10. 2016.PubMed/NCBI

Tse G and Yan BP: Novel arrhythmic risk markers incorporating QRS dispersion: QRSd x (Tpeak - Tend)/QRS and QRSd x (Tpeak - Tend)/(QT x QRS). Ann Noninvasive Electrocardiol. Aug 18–2016.Epub ahead of print. View Article : Google Scholar

Tse G, Lai ET, Lee AP, Yan BP and Wong SH: Electrophysiological mechanisms of gastrointestinal arrhythmogenesis: Lessons from the heart. Front Physiol. 7:2302016.PubMed/NCBI

Tse G and Yan BP: Traditional and novel electrocardiographic conduction and repolarization markers of sudden cardiac death. Europace. Oct 4–2016.Epub ahead of print. View Article : Google Scholar

Tse G, Yan BP, Chan YW, Tian XY and Huang Y: Reactive oxygen species, endoplasmic reticulum stress and mitochondrial dysfunction: The link with cardiac arrhythmogenesis. Front Physiol. 7:3132016. View Article : Google Scholar : PubMed/NCBI

Sun B, Chen Z, Gu J, Tse G, Jiang J, Huang F and Zhao C: Tight junction proteins and gap junction proteins play important roles in high fat dietary atherosclerosis pathogenesis. Int J Clin Exp Pathol. 9:7969–7976. 2016.

Tse G, Ali A, Prasad SK, Vassiliou V and Raphael CE: Atypical case of post-partum cardiomyopathy: an overlap syndrome with arrhythmogenic right ventricular cardiomyopathy? BJR|case reports. 1:201501822015. View Article : Google Scholar

Tse G, Ali A, Alpendurada F, Prasad S, Raphael CE and Vassiliou V: Tuberculous constrictive pericarditis. Res Cardiovasc Med. 4:e296142015. View Article : Google Scholar

Mayosi BM, Ntsekhe M, Bosch J, Pandie S, Jung H, Gumedze F, Pogue J, Thabane L, Smieja M, Francis V, et al IMPI Trial Investigators: Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med. 371:1121–1130. 2014. View Article : Google Scholar : PubMed/NCBI

Vassiliou V, Chin C, Perperoglou A, Tse G, Ali A, Raphael C, Jabbour A, Newby D, Pennell D, Dweck M and Prasad S: 93 Ejection fraction by cardiovascular magnetic resonance predicts adverse outcomes post aortic valve replacement. Heart. 100(Suppl 3): A53–A54. 2014. View Article : Google Scholar

Tse G, Hothi SS, Grace AA and Huang CL: Ventricular arrhythmogenesis following slowed conduction in heptanol-treated, Langendorff-perfused mouse hearts. J Physiol Sci. 62:79–92. 2012. View Article : Google Scholar : PubMed/NCBI

Wong J, Tan T, Chan C, Laxton V, Chan Y, Liu T, Wong J and Tse G: The role of connexins in wound healing and repair: novel therapeutic approaches. Front Physiol. 7:5962016. View Article : Google Scholar : PubMed/NCBI